Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 25.54B | 24.99B | 27.11B | 23.62B | 22.44B |
Gross Profit | 3.79B | 3.80B | 3.54B | 3.07B | 2.69B |
EBITDA | 2.59B | 2.50B | 3.46B | 1.92B | 1.88B |
Net Income | 746.44M | 796.77M | 1.49B | 523.15M | 542.24M |
Balance Sheet | |||||
Total Assets | 38.38B | 38.14B | 37.84B | 36.88B | 33.78B |
Cash, Cash Equivalents and Short-Term Investments | 5.27B | 5.61B | 5.03B | 4.11B | 5.01B |
Total Debt | 8.54B | 9.48B | 10.34B | 10.85B | 9.45B |
Total Liabilities | 13.96B | 14.59B | 15.92B | 16.80B | 14.49B |
Stockholders Equity | 21.31B | 20.62B | 19.28B | 17.64B | 17.07B |
Cash Flow | |||||
Free Cash Flow | 966.62M | 1.60B | 1.80B | -2.07B | -1.17B |
Operating Cash Flow | 2.45B | 2.15B | 2.68B | 1.32B | 1.37B |
Investing Cash Flow | -1.18B | -754.05M | -1.65B | -2.13B | -3.91B |
Financing Cash Flow | -1.14B | -1.02B | -948.09M | 1.21B | 1.09B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥8.80B | 11.78 | 2.43% | 2.20% | -6.32% | ||
80 Outperform | ¥12.11B | 13.23 | 2.30% | 14.84% | 7.57% | ||
80 Outperform | ¥26.39B | 16.33 | 2.59% | 5.01% | -5.30% | ||
76 Outperform | ¥12.98B | 13.71 | 1.51% | 3.54% | 6.14% | ||
72 Outperform | ¥5.07B | 5.88 | 2.35% | 0.16% | 100.58% | ||
72 Outperform | ¥54.33B | 18.96 | 1.87% | 11.47% | 21.72% | ||
65 Neutral | $11.06B | 15.73 | 5.16% | 1.93% | 3.12% | -25.59% |